hydroxyindoleacetic acid has been researched along with Cognition Disorders in 14 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study we investigated the cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) in Alzheimer (AD) patients (n=75), patients with mild cognitive impairment (MCI, n=9) and patients with depression (n=7)." | 7.72 | 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment. ( Ganzer, S; Müller-Thomsen, T; Stuerenburg, HJ, 2004) |
| "In this study we investigated the cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) in Alzheimer (AD) patients (n=75), patients with mild cognitive impairment (MCI, n=9) and patients with depression (n=7)." | 3.72 | 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment. ( Ganzer, S; Müller-Thomsen, T; Stuerenburg, HJ, 2004) |
| "Lewy body disorders, including Parkinson's disease (PD), Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), are characterized by profound central and peripheral monoaminergic dysfunction." | 1.48 | Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease. ( Aerts, T; De Deyn, PP; Fransen, E; Gerritsen, MJ; Spikman, JM; Van Dam, D; van der Zee, S; van Laar, T; Vermeiren, Y, 2018) |
| "Schizophrenia is associated with multiple cognitive deficits which in turn may be related to abnormal dopamine (DA) function." | 1.29 | Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function. ( Apter, S; Davidson, M; Davis, KL; Harvey, PD; Kahn, RS; Keefe, RS; Mohs, RC; Neale, JM, 1994) |
| "In patients with Parkinson's disease the levels of somatostatin-like immunoreactivity were lower than in controls (P less than ." | 1.28 | Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy. ( Cramer, H; Kuntzmann, F; Masson, H; Popescu, I; Strubel, D, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Zee, S | 1 |
| Vermeiren, Y | 1 |
| Fransen, E | 1 |
| Van Dam, D | 1 |
| Aerts, T | 1 |
| Gerritsen, MJ | 1 |
| Spikman, JM | 1 |
| van Laar, T | 1 |
| De Deyn, PP | 1 |
| Pudell, C | 1 |
| Vicente, BA | 1 |
| Delattre, AM | 1 |
| Carabelli, B | 1 |
| Mori, MA | 1 |
| Suchecki, D | 1 |
| Machado, RB | 1 |
| Zanata, SM | 1 |
| Visentainer, JV | 1 |
| de Oliveira Santos Junior, O | 1 |
| Lima, MM | 1 |
| Ferraz, AC | 1 |
| Luo, J | 1 |
| Wang, T | 1 |
| Liang, S | 1 |
| Hu, X | 1 |
| Li, W | 1 |
| Jin, F | 1 |
| Pomara, N | 1 |
| Willoughby, LM | 1 |
| Hashim, A | 1 |
| Sershen, H | 1 |
| Sidtis, JJ | 1 |
| Wesnes, K | 1 |
| Greenblatt, DJ | 1 |
| Lajtha, A | 1 |
| Pardon, MC | 1 |
| Hanoun, N | 1 |
| Perez-Diaz, F | 1 |
| Joubert, C | 1 |
| Launay, JM | 1 |
| Christen, Y | 1 |
| Hamon, M | 1 |
| Cohen-Salmon, C | 1 |
| Stuerenburg, HJ | 1 |
| Ganzer, S | 1 |
| Müller-Thomsen, T | 1 |
| Leckman, JF | 1 |
| Cohen, DJ | 1 |
| Shaywitz, BA | 1 |
| Caparulo, BK | 1 |
| Heninger, GR | 1 |
| Bowers, MB | 1 |
| McEntee, WJ | 1 |
| Mair, RG | 1 |
| Langlais, PJ | 1 |
| Kahn, RS | 1 |
| Harvey, PD | 1 |
| Davidson, M | 1 |
| Keefe, RS | 1 |
| Apter, S | 1 |
| Neale, JM | 1 |
| Mohs, RC | 1 |
| Davis, KL | 1 |
| Shimada, A | 1 |
| Yamaguchi, K | 1 |
| Yanagita, T | 1 |
| Masson, H | 1 |
| Popescu, I | 1 |
| Strubel, D | 1 |
| Cramer, H | 1 |
| Kuntzmann, F | 1 |
| Faustman, WO | 1 |
| Faull, KF | 1 |
| Whiteford, HA | 1 |
| Borchert, C | 1 |
| Csernansky, JG | 1 |
| Hildebrand, J | 1 |
| Bourgeois, F | 1 |
| Buyse, M | 1 |
| Przedborski, S | 1 |
| Goldman, S | 1 |
| Mayeux, R | 1 |
| Stern, Y | 1 |
| Sano, M | 1 |
| Cote, L | 1 |
| Williams, JB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00004325] | 200 participants | Observational | 1988-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for hydroxyindoleacetic acid and Cognition Disorders
| Article | Year |
|---|---|
Effects of acute lorazepam administration on aminergic activity in normal elderly subjects: relationship to performance effects and apolipoprotein genotype.
Topics: Aged; Analysis of Variance; Anti-Anxiety Agents; Apolipoprotein E4; Apolipoproteins; Apolipoproteins | 2004 |
13 other studies available for hydroxyindoleacetic acid and Cognition Disorders
| Article | Year |
|---|---|
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
Topics: Aged; Biogenic Monoamines; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Diagnosis, Differ | 2018 |
Fish oil improves anxiety-like, depressive-like and cognitive behaviors in olfactory bulbectomised rats.
Topics: Animals; Anxiety Disorders; Brain-Derived Neurotrophic Factor; Central Nervous System Agents; Cognit | 2014 |
Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat.
Topics: Animals; Anxiety; Brain; Cognition Disorders; Dinoprostone; Disease Models, Animal; Enzyme-Linked Im | 2014 |
Long-term treatment with the antioxidant drug EGb 761 at senescence restored some neurobehavioral effects of chronic ultramild stress exposure seen in young mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Behavior, Animal; Brain; Brain Chemist | 2004 |
5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Depression; Dopamine; Female; Homovanillic Acid; Human | 2004 |
CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
Topics: Adolescent; Adult; Age Factors; Aged; Autistic Disorder; Bipolar Disorder; Child; Child, Preschool; | 1980 |
Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders.
Topics: Alcohol Amnestic Disorder; Cognition Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacet | 1984 |
Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
Topics: Adult; Cerebral Cortex; Cognition Disorders; Discrimination Learning; Dopamine; Homovanillic Acid; H | 1994 |
Neurochemical analysis of the psychotoxicity of methamphetamine and cocaine by microdialysis in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Cognition Disorders; Corpus Striatum; Dopamine; Hy | 1996 |
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy.
Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Cognition Disorders; Female; Homovanillic Acid; | 1990 |
CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression.
Topics: Adult; Aged; Arousal; Cognition Disorders; Depressive Disorder; Dexamethasone; Female; Humans; Hydro | 1990 |
Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Cognition Disorders; Female; G | 1990 |
Clinical and biochemical correlates of bradyphrenia in Parkinson's disease.
Topics: Aged; Alzheimer Disease; Arousal; Attention; Biogenic Amines; Cognition Disorders; Homovanillic Acid | 1987 |